NO315496B1 - Anvendelse av beraprost for fremstilling av et medikament for behandling avcor pulmonale - Google Patents

Anvendelse av beraprost for fremstilling av et medikament for behandling avcor pulmonale Download PDF

Info

Publication number
NO315496B1
NO315496B1 NO19964497A NO964497A NO315496B1 NO 315496 B1 NO315496 B1 NO 315496B1 NO 19964497 A NO19964497 A NO 19964497A NO 964497 A NO964497 A NO 964497A NO 315496 B1 NO315496 B1 NO 315496B1
Authority
NO
Norway
Prior art keywords
cor pulmonale
pulmonary
beraprost
treatment
compound
Prior art date
Application number
NO19964497A
Other languages
English (en)
Norwegian (no)
Other versions
NO964497L (no
NO964497D0 (no
Inventor
Reiji Kasukawa
Masayuki Miyata
Yuji Ueno
Hiroshi Koike
Hajimu Kurumatani
Shintaro Nishio
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO964497L publication Critical patent/NO964497L/no
Publication of NO964497D0 publication Critical patent/NO964497D0/no
Publication of NO315496B1 publication Critical patent/NO315496B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Furan Compounds (AREA)
  • Steroid Compounds (AREA)
NO19964497A 1995-02-27 1996-10-23 Anvendelse av beraprost for fremstilling av et medikament for behandling avcor pulmonale NO315496B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3816995 1995-02-27
PCT/JP1996/000443 WO1996026721A1 (fr) 1995-02-27 1996-02-27 Remede pour le c×ur droit

Publications (3)

Publication Number Publication Date
NO964497L NO964497L (no) 1996-10-23
NO964497D0 NO964497D0 (no) 1996-10-23
NO315496B1 true NO315496B1 (no) 2003-09-15

Family

ID=12517905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964497A NO315496B1 (no) 1995-02-27 1996-10-23 Anvendelse av beraprost for fremstilling av et medikament for behandling avcor pulmonale

Country Status (13)

Country Link
US (1) US6046233A (fr)
EP (1) EP0759297B1 (fr)
JP (1) JP4062743B2 (fr)
CN (1) CN1127336C (fr)
AT (1) ATE316788T1 (fr)
AU (1) AU4732096A (fr)
CA (1) CA2188931C (fr)
DE (1) DE69635775T2 (fr)
ES (1) ES2252751T3 (fr)
FI (1) FI964303A0 (fr)
NO (1) NO315496B1 (fr)
TW (1) TW419374B (fr)
WO (1) WO1996026721A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0925787A4 (fr) * 1997-02-27 1999-12-01 Toray Industries Medicaments permettant d'ameliorer la circulation pulmonaire
US20100048693A1 (en) * 2006-12-04 2010-02-25 The Regents Of The University Of Colorado, A Body Corporate Treatment of COPD
ES2817557T3 (es) 2008-02-28 2021-04-07 Nippon Shinyaku Co Ltd Inhibidor de fibrosis
JP2012510964A (ja) * 2008-12-05 2012-05-17 インターメッド・ディスカバリー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Ｈｉｆ−１蛋白蓄積の阻害剤
WO2014046065A1 (fr) 2012-09-21 2014-03-27 国立大学法人大阪大学 Matériau de traitement de l'insuffisance cardiaque avancée utilisé comme dispositif de régénération cardiovasculaire/du myocarde
ES2733998T3 (es) 2012-10-29 2019-12-03 Cardio Incorporated Agente terapéutico específico de enfermedad pulmonar
US9968716B2 (en) 2013-10-15 2018-05-15 Ono Pharmaceutical Co., Ltd. Drug-eluting stent graft

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
JPH0240325A (ja) * 1988-06-17 1990-02-09 Wellcome Found Ltd:The 医薬用化合物
GB8824187D0 (en) * 1988-10-14 1988-11-23 Wellcome Found Compounds for use in medicine
US5496850A (en) * 1991-04-11 1996-03-05 Toray Industries, Inc. Antimetastasis agent of malignant tumors
CA2107669C (fr) * 1992-02-07 2004-06-01 Makoto Okumura Preparation pour le traitement des lesions et des hemorroides
JP3102141B2 (ja) * 1992-05-29 2000-10-23 東レ株式会社 養毛育毛剤
US6083501A (en) * 1994-06-07 2000-07-04 Toray Industries, Inc. Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases

Also Published As

Publication number Publication date
FI964303L (fi) 1996-10-25
EP0759297A4 (fr) 2003-11-12
EP0759297B1 (fr) 2006-02-01
TW419374B (en) 2001-01-21
JP4062743B2 (ja) 2008-03-19
CN1127336C (zh) 2003-11-12
FI964303A7 (fi) 1996-10-25
WO1996026721A1 (fr) 1996-09-06
NO964497L (no) 1996-10-23
DE69635775D1 (de) 2006-04-13
ES2252751T3 (es) 2006-05-16
DE69635775T2 (de) 2006-08-10
CA2188931C (fr) 2007-09-11
EP0759297A1 (fr) 1997-02-26
ATE316788T1 (de) 2006-02-15
CN1147765A (zh) 1997-04-16
AU4732096A (en) 1996-09-18
NO964497D0 (no) 1996-10-23
US6046233A (en) 2000-04-04
FI964303A0 (fi) 1996-10-25
CA2188931A1 (fr) 1996-09-06

Similar Documents

Publication Publication Date Title
Sparr et al. Newer neuromuscular blocking agents: how do they compare with established agents?
DE60027985T2 (de) Behandlung von Lungenhochdruck
Goldberg et al. Hyperglycemic, nonketotic coma following administration of Dilantin (diphenylhydantoin)
JP4606581B2 (ja) Ｉｃｕ鎮静のためのデクスメデトミジンの用途
Toivonen Anaesthesia for patients with a transplanted organ
Baker et al. Intentional asystole during endoluminal thoracic aortic surgery without cardiopulmonary bypass.
Miller et al. Bolus administration of esmolol for the treatment of intraoperative myocardial ischaemia
Stirt et al. Aminophylline
DE69812028T2 (de) Creatine Derivate für Asthma
Hill et al. Studies of the effects of inhaled magnesium on airway reactivity to histamine and adenosine monophosphate in asthmatic subjects
EP2157089B1 (fr) Utilisations thérapeutiques de dérivés d'acide imidazol-5-carboxylique.
EP0759297B1 (fr) Remede pour le coeur droit
Vandenbergh et al. Conservative treatment of acute respiratory failure in patients with chronic obstructive lung disease
Hong et al. Importance of membrane stabilizing effect in massive overdose of propranolol: plasma level study in a fatal case
CN1314815A (zh) 用于免疫调节的药物组合物
Casthely et al. Ketanserin in the preoperative and intraoperative management of a patient with carcinoid tumor undergoing tricuspid valve replacement
Kundra et al. Sevoflurane-induced arrhythmia in an adult and a child
US4315003A (en) Compositions containing azo compounds and use thereof for therapeutic treatment
US4814336A (en) Method of treating a vascular obstructive lesion resulting from restricted blood circulation
DE3887426T2 (de) Eperisone als Hypotonikum.
Calle et al. Nimodipine has no beneficial effect on neurological outcome in a cardiopulmonary arrest model in the rat
Langemeijer et al. Respiratory Arrest as Main Determinant of Toxicity due to Overdose with Different β–Blockers in Rats
WO1997044031A1 (fr) Agent de traitement de l'eczema allergique
DE3239714C2 (de) Verwendung von 5-Methyl-7-dietylamino-s-triazolo-(1,5-a)-pyrimidin zusammen mit einem }blichen pharmazeutisch annehmbaren Tr{ger zur Behandlung von chronischen okklusiven Lungenerkrankungen
EP0547508A1 (fr) Utilisation de dérivés de xanthine pour la stabilisation de l'autorégulation de l'irrigation du cerveau

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees